Evidence map›Paper›PMID 32619481›Full record

ArticleCurrent biology : CB2020

A Non-canonical BRCT-Phosphopeptide Recognition Mechanism Underlies RhoA Activation in Cytokinesis.

J Sebastián Gómez-Cavazos, Kian-Yong Lee, Pablo Lara-González, Yanchi Li, Arshad Desai, Andrew K Shiau, Karen Oegema

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

J Sebastián Gómez-CavazosLudwig Institute for Cancer Research, La Jolla, CA 92093, USA; Section of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: s9gomez@ucsd.edu.
Kian-Yong LeeLudwig Institute for Cancer Research, La Jolla, CA 92093, USA.
Pablo Lara-GonzálezLudwig Institute for Cancer Research, La Jolla, CA 92093, USA.
Yanchi LiLudwig Institute for Cancer Research, La Jolla, CA 92093, USA.
Arshad DesaiLudwig Institute for Cancer Research, La Jolla, CA 92093, USA; Section of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Andrew K ShiauSection of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA; Small Molecule Discovery Program, Ludwig Institute for Cancer Research, La Jolla, CA 92093, USA.
Karen OegemaLudwig Institute for Cancer Research, La Jolla, CA 92093, USA; Section of Cell and Developmental Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA. Electronic address: koegema@health.ucsd.edu.
Ludwig Cancer Research · USUniversity of California, San Diego · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Determining How The Chromosome Passenger Complex and Polo-like Kinase 1 Control CytokinesisF32GM125347 · NIGMS · LUDWIG INSTITUTE FOR CANCER RES LTD · PI GOMEZ CAVAZOS, JUAN SEBASTIAN · 2017 to 2017
$61k
NCI NIH HHS P30 CA023100NCI NIH HHS T32 CA067754NIGMS NIH HHS F32 GM125347
6 · The paper itself

Abstract

Cytokinesis partitions the cell contents to complete mitosis. During cytokinesis, polo-like kinase 1 (PLK1) activates the small GTPase RhoA to assemble a contractile actomyosin ring. PLK1 is proposed to pattern RhoA activation by creating a docking site on the central spindle that concentrates the RhoA guanine nucleotide exchange factor ECT2. However, ECT2 targeting to the central spindle is dispensable for cytokinesis, indicating that how PLK1 controls RhoA activation remains unresolved. To address this question, we employed an unbiased approach targeting ∼100 predicted PLK1 sites in two RhoA regulators: ECT2 and the centralspindlin complex, composed of CYK4 and kinesin-6. This comprehensive approach suggested that the only functionally critical PLK1 target sites are in a single cluster in the CYK4 N terminus. Phosphorylation of this cluster promoted direct interaction of CYK4 with the BRCT repeat module of ECT2. However, mutational analysis in vitro and in vivo led to the surprising finding that the interaction was independent of the conserved "canonical" residues in ECT2's BRCT repeat module that, based on structurally characterized BRCT-phosphopeptide interactions, were presumed critical for binding. Instead, we show that the ECT2 BRCT module binds phosphorylated CYK4 via a distinct conserved basic surface. Basic surface mutations mimic the effects on cytokinesis of loss of CYK4 cluster phosphorylation or inhibition of PLK1 activity. Together with evidence for ECT2 autoinhibition limiting interaction with CYK4 in the cytoplasm, these results suggest that a spatial gradient of phosphorylated CYK4 around the central spindle patterns RhoA activation by interacting with ECT2 on the adjacent plasma membrane.

Indexed as

CytokinesisAnimalsBRCA1 ProteinCaenorhabditis elegansCaenorhabditis elegans ProteinsCell Cycle ProteinsGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsHeLa CellsHumansPhosphopeptidesPhosphorylationPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsrhoA GTP-Binding ProteinBRCA1 ProteinBRCA1 protein, humanCaenorhabditis elegans ProteinsCell Cycle ProteinsEct-2 protein, C elegansGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsmgcRacGAPPhosphopeptidesPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsrhoA GTP-Binding ProteinRHOA protein, humanBRCT domaincell divisioncentralspindlincytokinesisEct2MgcRacGAPPlk1RACGAP1RhoAsmall GTPase

Identifiers

PMID32619481
PMCPMC7438317
OpenAlexW3038257345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.